Material Type

• Blood (whole) (1)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Isolated peripheral blood mononuclear cells (viable) (1)
• Plasma (single spun) (1)
• Saliva (1)
• Serum (3)
• Swab medium (1)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Non-affected (1)
• Not applicable (3)

Storage Temperature

• RT (1)
• -85°C to -60°C (3)
• Liquid nitrogen (1)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (2)
• Clinical records (3)
• Followup records (3)
• Freezer temperature logs (3)
• Microbiological results (1)
• Physiological/biochemical measurements (1)
• Pre-analytical data (2)
• Quality indicators (1)
• Survey data (2)
• Treatment records (3)

Timeframe

• Immediate (2)
• 0 - 3 months (3)
• 3 - 6 months (4)
• > 6 months (2)

Participant Count

• 11 - 100 (4)

Sex

• Unknown (1)
• Both sexes (3)

Age Range

• Child (6 - 12 years) (1)
• Adolescent (12 - 18 years) (2)
• Young adult (18 - 40 years) (1)
• Adult (> 40 years) (2)

Biobank Services

• Cell culture (1)
• Immunohistochemistry - staining (1)
• Molecular Extractions (1)
• Nucleic acid extraction (2)

Collection Type

• Cohort (2)
• Cross-sectional (1)
• Disease specific (2)

Consent Restriction

• No Commercial restriction (3)
• No Disease area restriction (3)
• No Export restriction (4)
• No Genetic analysis restriction (2)
• No Human genetic analysis restriction (3)
• No restrictions (1)
• No Project specific restriction (4)
• No Scope of use restriction (3)

Collection Status

• Completed (2)
• In progress (2)
• Not-started (1)

Access Condition

• Open to applicants (2)
• Open only through collaboration (1)
• Closed to access (1)

Country

• Germany (1)
• Peru (1)
• Switzerland (1)
• United Kingdom of Great Britain and Northern Ireland (1)
• United States (1)

County